Biofilm formation by Candida dubliniensis

Journal of Clinical Microbiology

Volumn 39, Issue 9, 2001, Pages 3234-3240

  Ramage, G ^a   Walle, K V ^a   Wickes, B L ^a   Lopez Ribot J L ^a  

^a South Texas Ctr for Biol in Med ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC ACID; AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; POLYSTYRENE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDIASIS; FUNGUS CULTURE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; CANDIDIASIS, ORAL; HUMANS; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; PLASMA; POLYMETHYL METHACRYLATE; POLYSTYRENES; SALIVA;

CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0034837301     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.9.3234-3240.2001     Document Type: Article

References (65)

1. Candida biofilms and their susceptibility to antifungal agents
2. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents
3. Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B
4. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents
5. Role of dimorphism in the development of Candida albicans biofilms
6. Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes
7. Adhesion to silicone rubber of yeasts and bacteria isolated from voice prostheses: Influence of salivary conditioning films
8. Oral colonization by Candida albicans
9. Bacterial metabolism in dental biofilms
10. Cell wall and secreted proteins of Candida albicans: Identification, function, and expression
11. Immunologic aspects of oral candidiasis
12. Molecular and phenotypic analysis of Candida dubliniensis: A recently identified species linked with oral candidosis in HIV-infected and AIDS patients
13. Importance of Candida species other than Candida albicans as opportunistic pathogens
14. Candida dubliniensis
15. Microbial biofilms
16. Bacterial biofilms: A common cause of persistent infections
17. Identification of Candida dubliniensis based on temperature and utilization of xylose and alpha-methyl-D- glucoside as determined with the API 20C AUX and vitek YBC systems
18. Bacterial biofilms: Resistance to antimicrobial agents
19. Biofilm susceptibility to antimicrobials
20. Candida dubliniensis: Phylogeny and putative virulence factors
21. Phenotypic and genotypic characterization of oral yeasts from Finland and the United States
22. Adhesion of different Candida spp. to plastic: XTT formazan determinations
23. Biofilm formation by Candida species on the surface of catheter materials in vitro
24. Resistance of Candida albicans biofilms to antifungal agents in vitro
25. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents
26. Comparison of the hydrophobic properties of Candida albicans and Candida dubliniensis
27. Interactions of Candida albicans with bacteria and salivary molecules in oral biofilms
28. Candida dubliniensis and Candida albicans display surface variations consistent with observed intergeneric coaggregation
29. Identification of Candida dubliniensis in a prospective study of patients in the United States
30. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals
31. Coaggregation of Candida dubliniensis with Fusobacterium nucleatum
32. Increased resistance to antifungal antibiotics of Candida spp. adhered to silicone
33. Growth competition between Candida dubliniensis and Candida albicans under broth and biofilm growing conditions
34. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates
35. Riddle of biofilm resistance
36. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea
37. Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States
38. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis
39. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro
40. Effects of salivary or serum pellicles on the Candida albicans growth and biofilm formation on soft lining materials in vitro
41. Interactions between denture lining material, protein pellicles and Candida albicans
42. Interactions between thermal cycled resilient denture lining materials, salivary and serum pellicles and Candida albicans in vitro. Part II. Effects on fungal colonization
43. Effects of dietary sugars and saliva and serum on Candida biofilm formation on acrylic surfaces
44. Effects of modified pellicles on Candida biofilm formation on acrylic surfaces
45. Effect of serum concentration on Candida biofilm formation on acrylic surfaces
46. Prevalence of Candida dubliniensis isolates in a yeast stock collection
47. Genetic approaches to study of biofilms
48. Modern microscopy in biofilm research: Confocal microscopy and other approaches
49. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents
50. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans
51. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents
52. Adherence of Candida albicans to denture-base materials with different surface finishes
53. Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS
54. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients
55. The role of Candida dubliniensis in oral candidiasis in human immunodeficiency virus-infected individuals
56. Colonization of Candida albicans on cleaned human dental hard tissues
57. Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis
58. Candida dubliniensis: An emerging opportunistic pathogen
59. Candida dubliniensis: Characteristics and identification
60. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals
61. Candida dubliniensis sp. nov.: Phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals
62. Innovative endpoint determination system for antifungal susceptibility testing of yeasts
63. Biofilm, city of microbes
64. The effect of sodium hypochlorite on potential pathogenic traits of Candida albicans and other Candida species